|

Benmelstobart Clinical Trials

3 actively recruiting trials

Also known as: TQB2450

Pipeline

Phase 2: 3

Top Sponsors

  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1
  • Shanghai Pulmonary Hospital, Shanghai, China1
  • Fudan University1

Indications

  • Cancer3
  • Breast Cancer2
  • Hormone Receptor Negative Tumor1
  • Hormone Receptor Positive Tumor1
  • Locally Advanced Breast Cancer1

Other3 trials

Adjuvant Benmelstobart for Stage IB, Grade 3 Invasive Lung Adenocarcinoma
Phase 2
Circulating Tumor DNA Guided Boost Therapy in Early Triple Negative Breast Patients With Residual Disease After Neoadjuvant Therapy
Phase 2
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.